Lori J. Goldstein, MD, FASCO
Breast cancer remains one of the most common malignancies among women, second only in incidence to lung cancer. For the first time since 1950, breast cancer death rates for American women declined nearly 5% between 1989 and 1992. Two plausible explanations for the decline are an increase in breast cancer awareness leading to early detection, and adjuvant systemic therapy for both node positive and node negative breast cancer. In an effort to contribute to the reduction of both the incidences of breast cancer and the morbidity and mortality due to this disease, we have developed a multidisciplinary program encompassing basic, clinical, and prevention and control research.